DUSAVI
DEAD

Serial Number

87641236

Owner

Teva Pharmaceuticals USA, Inc.

Filing Date

Oct 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

DUSAVI Trademark

Serial Number: 87641236

DUSAVI is a trademark filed by Teva Pharmaceuticals USA, Inc. on October 11, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (587 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

October 11, 2017

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 20, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 20, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 8, 2021 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 8, 2021 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 15, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 14, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 11, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 11, 2019 RCSC
ASSIGNED TO LIE
Jan 11, 2019 ALIE
UNDELIVERABLE MAIL - COURTESY COPY MAILED
Jun 7, 2018 UNDC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 31, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
May 31, 2018 GNSL
SUSPENSION LETTER WRITTEN
May 31, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 11, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 11, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 11, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 18, 2017 NWOS
NEW APPLICATION ENTERED
Oct 14, 2017 NWAP